Yichen Li
Impact in
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Long-Term Effects of COVID-19
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
Papers in
-
- Gut microbiota and health 5
- Mechanisms of cancer metastasis 2
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Lixin Zhu (14 shared papers)Sijing Cheng (11 shared papers)Ping Lan (9 shared papers)Na Jiao (10 shared papers)Ruixin Zhu (9 shared papers)Yifeng Zou (7 shared papers)Dingfeng Wu (4 shared papers)Yibo Huang (8 shared papers)
- Journals
- Emerging Microbes & Infections (2 papers)The FASEB Journal (2 papers)Signal Transduction and Targeted Therapy (2 papers)The Lancet. Gastroenterology & hepatology (2 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yichen Li
65 papers receiving 1.8k citations
Yichen Li's Hit Papers
Peers
Comparison fields: 5 of 118
- Neurology 476
- Infectious Diseases 172
- Molecular Biology 535
- Oncology 147
- Cancer Research 86
Countries citing papers authored by Yichen Li
This map shows the geographic impact of Yichen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Li more than expected).
Fields of papers citing papers by Yichen Li
This network shows the impact of papers produced by Yichen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Li. The network helps show where Yichen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yichen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons Hit paper breakdown → | 2018 | 457 |
| 2 | 2021 | 201 | |
| 3 | 2020 | 130 | |
| 4 | 2021 | 92 | |
| 5 | 2021 | 83 | |
| 6 | 2023 | 79 | |
| 7 | 2017 | 74 | |
| 8 | 2019 | 60 | |
| 9 | 2022 | 40 | |
| 10 | 2021 | 39 | |
| 11 | 2023 | 38 | |
| 12 | 2018 | 36 | |
| 13 | 2022 | 36 | |
| 14 | 2018 | 32 | |
| 15 | 2020 | 28 | |
| 16 | 2022 | 28 | |
| 17 | 2016 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2024 | 24 | |
| 20 | 2024 | 23 |
About Yichen Li
Yichen Li is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Cancer Research and Neurology, having authored 70 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), COVID-19 Clinical Research Studies (5 papers), Gut microbiota and health (5 papers), Amyotrophic Lateral Sclerosis Research (3 papers), Down syndrome and intellectual disability research (2 papers), Dementia and Cognitive Impairment Research (2 papers), Machine Learning in Healthcare (2 papers) and Mechanisms of cancer metastasis (2 papers). The work is most often cited by research in Neurology (476 citations), Infectious Diseases (172 citations), Molecular Biology (535 citations), Oncology (147 citations) and Cancer Research (86 citations). Yichen Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lixin Zhu, Sijing Cheng, Ping Lan, Na Jiao, Ruixin Zhu, Yifeng Zou, Dingfeng Wu, Yibo Huang, Xutao Lin and Ming‐Liang He. Their work appears in journals such as Emerging Microbes & Infections, The FASEB Journal, Signal Transduction and Targeted Therapy, The Lancet. Gastroenterology & hepatology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.